Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Drug Discov Today. 2022 Mar;27(3):759-776. doi: 10.1016/j.drudis.2021.12.001. Epub 2021 Dec 8.
Tubulin is an important cancer drug target. Compounds that bind at the colchicine site in tubulin have attracted significant interest as they are generally less affected by multidrug resistance than other potential drugs. Modeling is useful in understanding the interactions between tubulin and colchicine binding site inhibitors (CBSIs), but because the colchicine binding site contains two flexible loops whose conformations are highly ligand-dependent, modeling has its limitations. X-ray crystallography provides experimental pictures of tubulin-ligand interactions at this challenging colchicine site. Since 2004, when the first X-ray structure of tubulin in complex with N-deacetyl-N-(2-mercaptoacetyl)-colchicine (DAMA-colchicine) was published, many X-ray crystal structures have been reported for tubulin complexes involving the colchicine binding site. In this review, we summarize the crystal structures of tubulin in complexes with various CBSIs, aiming to facilitate the discovery of new generations of tubulin inhibitors.
微管蛋白是一种重要的癌症药物靶点。与微管蛋白上的秋水仙素结合部位结合的化合物引起了人们的极大兴趣,因为它们通常比其他潜在药物受多药耐药性的影响更小。建模对于理解微管蛋白与秋水仙素结合部位抑制剂(CBSI)之间的相互作用非常有用,但由于秋水仙素结合部位包含两个灵活的环,其构象高度依赖于配体,因此建模存在局限性。X 射线晶体学为这个具有挑战性的秋水仙素结合部位的微管蛋白-配体相互作用提供了实验图像。自 2004 年首次发表微管蛋白与 N-去乙酰基-N-(2-巯基乙酰基)-秋水仙碱(DAMA-秋水仙碱)复合物的 X 射线结构以来,已经报道了许多涉及秋水仙素结合部位的微管蛋白复合物的 X 射线晶体结构。在这篇综述中,我们总结了与各种 CBSI 结合的微管蛋白的晶体结构,旨在促进新一代微管蛋白抑制剂的发现。